April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in a Good Layout Opportunity_Oriental Fortune Network

  • Post date April 6, 2022 — 11:35 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000538 000999 002368 002603 300049 300122 300170 300171 300181 300358 300713 300760 ADD Industry Beijing Tongrentang China Resources Sanjiu Medical & Pharmaceutical China Sports Industry Group Chongqing Taiji Industry Chongqing Zhifei Biological Products Fortune Ng Fung Food Hand Enterprise Solutions Inner Mongolia Furui Medical Science Jiangsu Hengrui Medicine Shanghai Runda Medical Technology Shanghai Tofflon Science And Technology Shenzhen Mindray Bio-Medical Electronics Shenzhenrease Technology Shijiazhuang Yiling Pharmaceutical Southwest Securities Tianjin Zhongxin Pharmaceutical Group Corporation Truking Technology Limited Wuxi Apptec Yunnan Baiyao Group Zhangzhou Pientzehuang Pharmaceutical Zhejiang Jolly Pharmaceutical Zhejiang Shouxiangu Pharmaceutical Science, Technology Conflict, War, Peace Strategy, Marketing Annual, Special Corporate Meeting Research, Development Health, Beauty Product Pharmaceutical Electricity Production, Distribution Insurance Market, Exchange Securities Stocks Epidemic Medicine Health Insurance Biology Technology, Engineering Small, Medium Enterprise Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data